Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
1
CIMA_AEMPS:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Study of GENEVAX-HIV, a Possible Vaccine
Phase 1
Completed
- Conditions
- HIV InfectionsHIV Seronegativity
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Wyeth-Lederle Vaccines
- Registration Number
- NCT00002232
- Locations
- 🇺🇸
Walter Reed Army Institute of Research, Washington, District of Columbia, United States
Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers
Phase 1
Completed
- Conditions
- HIV SeronegativityHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Wyeth-Lederle Vaccines
- Registration Number
- NCT00002231
- Locations
- 🇺🇸
Univ of Pennsylvania Med Ctr, Philadelphia, Pennsylvania, United States
News
No news found